rs144708625

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001278116.2(L1CAM):​c.396C>T​(p.Ala132=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00042 in 1,203,587 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 122 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., 27 hem., cov: 21)
Exomes 𝑓: 0.00034 ( 0 hom. 95 hem. )

Consequence

L1CAM
NM_001278116.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -4.82
Variant links:
Genes affected
L1CAM (HGNC:6470): (L1 cell adhesion molecule) The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family. The ectodomain, consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III), is linked via a single transmembrane sequence to a conserved cytoplasmic domain. This cell adhesion molecule plays an important role in nervous system development, including neuronal migration and differentiation. Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia, retardation, aphasia, spastic paraplegia and hydrocephalus). Alternative splicing of this gene results in multiple transcript variants, some of which include an alternate exon that is considered to be specific to neurons. [provided by RefSeq, May 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant X-153872156-G-A is Benign according to our data. Variant chrX-153872156-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 197139.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.82 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00121 (133/109733) while in subpopulation AFR AF= 0.00371 (112/30211). AF 95% confidence interval is 0.00315. There are 0 homozygotes in gnomad4. There are 27 alleles in male gnomad4 subpopulation. Median coverage is 21. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 27 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
L1CAMNM_001278116.2 linkuse as main transcriptc.396C>T p.Ala132= synonymous_variant 5/29 ENST00000370060.7 NP_001265045.1
L1CAMNM_000425.5 linkuse as main transcriptc.396C>T p.Ala132= synonymous_variant 4/28 NP_000416.1
L1CAMNM_024003.3 linkuse as main transcriptc.396C>T p.Ala132= synonymous_variant 4/27 NP_076493.1
L1CAMNM_001143963.2 linkuse as main transcriptc.381C>T p.Ala127= synonymous_variant 3/26 NP_001137435.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
L1CAMENST00000370060.7 linkuse as main transcriptc.396C>T p.Ala132= synonymous_variant 5/295 NM_001278116.2 ENSP00000359077 A1P32004-1

Frequencies

GnomAD3 genomes
AF:
0.00122
AC:
134
AN:
109682
Hom.:
0
Cov.:
21
AF XY:
0.000844
AC XY:
27
AN XY:
31998
show subpopulations
Gnomad AFR
AF:
0.00372
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000877
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00424
Gnomad NFE
AF:
0.000190
Gnomad OTH
AF:
0.00138
GnomAD3 exomes
AF:
0.000476
AC:
87
AN:
182747
Hom.:
0
AF XY:
0.000252
AC XY:
17
AN XY:
67331
show subpopulations
Gnomad AFR exome
AF:
0.00419
Gnomad AMR exome
AF:
0.000182
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000105
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000270
Gnomad OTH exome
AF:
0.000664
GnomAD4 exome
AF:
0.000340
AC:
372
AN:
1093854
Hom.:
0
Cov.:
30
AF XY:
0.000264
AC XY:
95
AN XY:
359480
show subpopulations
Gnomad4 AFR exome
AF:
0.00479
Gnomad4 AMR exome
AF:
0.000312
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000555
Gnomad4 FIN exome
AF:
0.0000247
Gnomad4 NFE exome
AF:
0.000254
Gnomad4 OTH exome
AF:
0.000392
GnomAD4 genome
AF:
0.00121
AC:
133
AN:
109733
Hom.:
0
Cov.:
21
AF XY:
0.000842
AC XY:
27
AN XY:
32059
show subpopulations
Gnomad4 AFR
AF:
0.00371
Gnomad4 AMR
AF:
0.000876
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000190
Gnomad4 OTH
AF:
0.00136
Alfa
AF:
0.000130
Hom.:
0
Bravo
AF:
0.00143
EpiCase
AF:
0.000273
EpiControl
AF:
0.000178

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingGeneDxMay 14, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJan 01, 2024L1CAM: BP4, BP7, BS2 -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsDec 29, 2017- -
Spastic paraplegia Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jun 29, 2014- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsNov 24, 2014This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.31
DANN
Benign
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs144708625; hg19: chrX-153137611; API